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Abstract
 
CD40–CD40 ligand (L) interactions play a pivotal role in immune-mediated inflammatory re-
sponses via the activation of antigen-presenting cells (APCs). To investigate the effects of con-
tinuous activation of resident tissue APCs, in this case the Langerhans cells (LCs) of the skin,
CD40L expression was targeted to the basal keratinocytes of the epidermis of mice using the
keratin-14 promoter. Approximately 80% of the transgenic (Tg) mice spontaneously developed
 
dermatitis on the ears, face, tail, and/or paws. Compared with littermates, Tgs had a 
 
 
 
90% de-
crease in epidermal LCs yet increased numbers within the dermis suggestive of enhanced emi-
gration of CD40-activated LCs. Tgs also displayed massive regional lymphadenopathy with in-
creased numbers of dendritic cells and B cells. Moreover, a decrease in IgM and an increase in
IgG1/IgG2a/IgG2b/IgE serum concentrations was detectable. Screening for autoantibodies re-
vealed the presence of antinuclear antibodies and anti-dsDNA antibodies implicative of sys-
temic autoimmunity. Accordingly, renal Ig deposits, proteinuria, and lung fibrosis were ob-
served. Adoptive transfer of T cells from Tgs to nonTg recipients evoked the development of
skin lesions similar to those found in the Tgs. Dermatitis also developed in B cell–deficient
CD40L Tg mice. These findings suggest that in situ activation of LCs by CD40L in the skin
not only leads to chronic inflammatory dermatitis but also to systemic mixed-connective-tis-
sue-like autoimmune disorders, possibly by breaking immune tolerance against the skin.
Key words: Langerhans cell • autoantibody • transgenic mice • mixed connective tissue 
disease • migration
 
Introduction
 
One of the initial steps in the induction of immune reac-
tions is the transport of antigen to the lymph node by
 
APCs, in particular dendritic cells (DCs)
 
*
 
. Immature DCs,
such as the Langerhans cells (LCs) of the epidermis, pre-
dominantly reside in peripheral tissues where they build a
network of sentinel cells that can acquire and process for-
eign antigens. Upon encountering exogenous antigens,
they mature and migrate to secondary lymphoid organs
where they present antigens to T cells. Only DCs have the
unique capacity to present antigens in the proper context of
the antigenic and costimulatory molecules required to
 
prime naive T cells (1). These costimulatory molecules in-
clude the members of the TNF/TNF-R family, the B7
family, and others. However, engagement of TNF/TNF-R
family molecules also induces activation and maturation of
DCs. In this respect, triggering of CD40 on DCs by
 
CD40L-expressing activated CD4
 
 
 
 T cells is one of the
strongest DC-activating signals known, and it has been
suggested that CD40–CD40L interactions are critical for T
cell help (2). In addition to DCs, CD40 is also prominently
expressed on B cells, where it plays an important role in
germinal center formation, isotype switching, and B cell
survival (3, 4).
In this study, the in vivo effects of continuous in situ ac-
tivation of tissue-specific resident APCs, the exemplary
model being the activation of epidermal DCs via CD40–
CD40L interactions, were examined in a transgenic (Tg)
mouse model. For this purpose, CD40L expression was tar-
geted to the basal keratinocytes using a keratin-14 expres-
sion cassette. Tg mice developed spontaneous inflamma-
tory skin lesions, which showed histopathologic features of
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chronic autoimmune disease. Ear sheets stained for I-A
 
 
 
LCs revealed an almost complete depletion (
 
 
 
90%) of LCs
in the epidermis and a profound in situ activation of the re-
maining LCs in Tg mice compared with littermates. In-
creased numbers of activated DCs were present in the der-
mis and in skin-draining lymph nodes, suggesting that
activated LCs emigrate at a higher rate from skin to drain-
ing lymph nodes. Tg mice also displayed massive regional
lymph node hyperplasia and splenomegaly with increased
numbers of DCs and B cells. Remarkably, CD40L Tgs de-
veloped a systemic autoimmune disease as evidenced by the
presence of autoantibodies including anti-dsDNA-antibod-
ies and autoreactive T cells. These disorders were accom-
panied by internal organ involvement, such as renal Ig
deposits, proteinuria, and inflammatory lung fibrosis. Ac-
cordingly, these animals had a significantly shorter life ex-
pectancy and finally succumbed to their disease. Transfer of
CD8
 
  
 
T cells from Tg mice to naive wild-type mice re-
sulted in the development of autoimmune skin inflamma-
tion in the recipients. These findings indicate that in situ
expression of CD40L in the skin not only leads to chronic
inflammatory (autoimmune) dermatitis, but surprisingly
also to systemic mixed-connective-tissue-like autoimmune
disorders. Thus, these data point to a possible role of acti-
vated DCs in the development of autoimmunity possibly
by breaking immune tolerance against tissues.
 
Materials and Methods
 
Transgene Construction and Production of Tg Mice.
 
The gene for
murine CD40 ligand (CD40L; provided by Immunex Corp.) was
placed under the control of the human K14 promoter (5, 6) using
standard methods as follows. The K14 expression cassette used in-
cluded the K14 promoter, a rabbit 
 
 
 
-globin intron, a multiple
cloning site, and the K14 polyadenylation site (7). The SalI/XbaI
fragment of the cDNA of CD40L was cloned into the SalI/XbaI
restriction site of the modified expression cassette thus creating
pAMM16. Plasmid DNA to be used for microinjections was pu-
rified twice using the JetStar Maxiprep Kit (Genomed). The ex-
pression cassette was digested with EcoRI/HindIII, extracted
from the agarose gel using the Jetsorb Kit (Genomed), resus-
pended in 10.0 mM Tris-HCl/0.1 mM EDTA, pH 7.4, and used
for microinjection into C57BL/6 
 
  
 
DBA F2 oocytes. Tg mice
were identified by either PCR (AM9: GTTCAGAGTTTGAG-
TAAGCCA; AM28: CAATGATATACACTGTTTGAGATGA;
cycling profile: 95
 
 
 
C for 5 min; [95
 
 
 
C for 1 min; 55
 
 
 
C for 40 s;
72
 
 
 
C for 1 min 
 
  
 
30; 72
 
 
 
C for 2 min]) or Southern blot analysis
of DNA isolated from tail. Three founder lines were established
by breeding into a DBA background. The line with the highest
Tg expression was selected for more extensive analysis. Most ex-
periments were carried out using heterozygous mice. Mice were
housed under specific pathogen free conditions according to in-
stitutional regulations.
 
Histology and Immunohistochemical Staining.
 
Tissues were fixed
in formalin and embedded in paraffin. Hematoxylin and eosin
(H&E) staining was performed by standard methods. Immunohis-
tochemistry was performed on cryostat sections (3–8 
 
 
 
m) fixed in
acetone according to standard methods. Slides were incubated in
the appropriate dilution of monoclonal antibody or isotype con-
trol and subsequently incubated with a horseradish peroxidase
 
(HRP)-coupled secondary antibody (Dianova). Peroxidase activ-
ity was visualized using 3-amino-9-ethyl-carbazol as a chro-
mogen. Tissues were counterstained with MAYER’S hemalum
solution (Merck KgaA). For further evaluation of the density of
LCs by electron microscopy, skin biopsies were fixed in Kar-
novsky’s solution, postfixed in 1% osmium tetroxide, embedded
in epon, ultrathin cut, and counterstained with uranyl acetate and
lead citrate.
 
Cell Preparations and Flow Cytometry.
 
Before flow cytometric
analyses, spleens and LNs were rubbed through a cell strainer. To
lyse erythrocytes, spleen cell suspensions were gently agitated in
lysis-buffer.
 
 
 
Expression of cell surface molecules was quantitated
by flow cytometry according to standard methods as follows.
Cells were incubated with monoclonal antibody against murine
pan macrophages (clone BM8; BMA Biomedicals AG): CD4
(RPA-T4; BD PharMingen); CD8 (RPA-T8; BD PharMingen);
CD11c (N418; Endogen); CD19 (ID3; BD PharMingen), CD40
(HM40-3; BD PharMingen), CD40L (MR1; BD PharMingen);
CD62L (Dreg 56; BD PharMingen), or I-A (clone M5/114;
Roche Diagnostics) and labeled with FITC-conjugated goat
anti–rat IgG or goat anti–hamster IgG (BD PharMingen or Di-
anova, respectively). Propidium iodide (100 nM; Sigma-Aldrich/
PBS) was added to detect dead cells. The cells were subsequently
analyzed in an EPICS-XL™ flow cytometer (Beckman Coulter).
 
Immunofluorescent Staining of Epidermal Ear Sheets.
 
Epidermal
sheets were stained essentially as described previously (8). In
brief, ears were mechanically split into dorsal and ventral sides,
incubated in 20 mM EDTA, pH 7.3, washed with PBS, and
fixed in acetone. Sheets were incubated in 1% BSA/PBS and
stained with the antibody overnight. Sheets were then incubated
with a FITC-coupled secondary antibody, mounted onto slides,
and examined using a Zeiss Axiovert microscope. Stained cells
were quantitated by microscopy. Positive cells in at least 16 ran-
domly selected visual fields of ocular grid of known area per ear
were counted.
 
Assay for Antinuclear Antibodies and Autoantibodies against
dsDNA.
 
Serum samples were screened for the presence of anti-
nuclear antibodies (ANAs) by indirect immunofluorescence on
HEp-2 cells (LD Labor Diagnostika). In brief, sera were diluted
in PBS before use, applied to the slides, and incubated overnight.
Slides were then incubated with FITC-coupled mouse Igs (Di-
anova), washed, and mounted. Staining patterns were assessed at
1:80 or 1:100 dilutions. Sera were screened for the presence of
anti-dsDNA antibodies using commercially available 
 
Crithidia lu-
cilidae
 
 slides (The Binding Site Ltd.). Sera were applied to the
slides at dilutions of 1:40. The slides were then incubated for 30
min with FITC-coupled mouse Igs (Dianova), washed, mounted,
and examined using a Zeiss Axiovert microscope.
 
Quantification of Serum Igs and Cytokines.
 
Levels of serum Igs
were quantitated using the ELISA-based Clonotyping System
HRP (Southern Biotechnology Associates, Inc.). Serum Igs
were detected with HRP-coupled antibodies specific for mouse
IgA, IgG1, IgG2a, IgG2b, IgG3, IgM, and IgE. To determine
differences in cytokine expression, serum or cell supernatants
were assayed by ELISA using the following antibody sets: IFN-
 
 
 
;
IL-4; IL-6; IL-12; and TNF-
 
 
 
 (OPTEIA assays; all from BD
PharMingen).
 
Detection of Ig Deposits.
 
Renal Ig deposits were detected on
cryostat sections of kidneys stained with FITC-coupled mouse
Igs (Dianova) diluted 1:30 in 0.9% saline solution. Ig deposits in
the skin were detected by a modified method described previ-
ously (9, 10). Cryostat sections were incubated with 1:10 dilu-
tions of serum and 1:100 dilutions of FITC-conjugated anti– 
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mouse Igs (Dianova). Sections were mounted and examined us-
ing a Zeiss Axiovert microscope.
 
Adoptive T Cell Transfer and Serum Transfer.
 
T cells (CD4
 
 
 
,
CD8
 
 
 
, and CD4
 
  
 
CD8
 
 
 
) were prepared from spleens and LNs of
CD40L Tg or age- and sex-matched control mice. LNs and
spleens were rubbed through a cell strainer and the resulting cell
suspension was prepurified by passing it over a nylon wool col-
umn. Subsequently, T cells were enriched by negative selection
using antibodies against non-T cells and separation via the
MACS
 
®
 
 technology as follows. Cells were incubated with the an-
tibodies anti-CD11b (M1/70), anti-CD16/32 (2.4G2), anti-
CD24 (M1/69), anti-CD45/B220 (RA3-6B2), anti–Gr-1/Ly-6G
(RB6-8C5), anti–
 
  
 
-T cells (GL3), anti–NK T cells (U5A2-13),
anti-CD4 (H129.19), or anti-CD8 (53-6.7), respectively (all pur-
chased from BD PharMingen) for 15 min at 4
 
 
 
C and subsequently
washed twice with PBS/1% FCS. Antibody-labeled cells were
then incubated for another 15 min at 4
 
 
 
C with anti–rat antibodies
conjugated with magnetic beads (Milteny Biotec). After washing
the cells twice with PBS/1% FCS/2 mM EDTA antibody-labeled
cells were separated via magnetic cell sorting (MACS
 
®
 
; Miltenyi
Biotec). The negative fraction was stained with antibodies for T
cells and analyzed by flow cytometry. Purity of T cells (CD3
 
 
 
)
was 94.4%, 89.2% for CD4
 
 
 
, and 87.6% for CD8
 
  
 
T cells. 10
 
7
 
CD4
 
 
 
, or CD8
 
  
 
T cells were injected intravenously into 5–6-
wk-old sex-matched (C57BL/6 
 
 
 
 DBA/F1) recipient control
mice (
 
n
 
   
 
6). Mice were monitored for 6 wk.
Serum was prepared from Tg or nonTg mice and 150 
 
 
 
l were
injected intravenously into nonTg mice (
 
n
 
    
 
6). Mice were
monitored for 6 wk.
 
Tracking of LC Migration.
 
Migration of LCs was monitored
using FITC as a tracer as described previously (11–13). In brief,
ears were treated with FITC (500 
 
 
 
g/15 
 
 
 
l dibutylphtalate/ace-
tone 1:1 supplemented with 5% DMSO; Sigma-Aldrich). The ret-
 
roauricular and cervical LNs were prepared 18 h later. Single cell
suspensions were stained for CD11c and subjected to flow cyto-
metric analyses.
 
Statistical Evaluation.
 
The significance of differences between
the mean values obtained for cytokine and Ig experiments was as-
sessed by the two-tailed Student’s 
 
t
 
 test for unpaired data.
Lifespan data was plotted using Kaplan and Meier curves and sig-
nificances were evaluated using a log-rank test.
 
 P 
 
values 
 
 
 
0.05
were regarded as being significant.
 
Results
 
Generation and Phenotype of CD40L Tg Mice.
 
To acti-
vate LCs in vivo, CD40L expression was targeted to the
epidermis of mice using the keratin-14 expression cassette
shown in Fig. 1 A. The expression of genes using this cas-
sette has been widely studied (14–17). The K14 promoter
drives the expression of genes in most basal cells of stratified
squamous epithelium including the epidermis, oral epithe-
lium, and palmoplantar skin (16, 18). Most of the noncod-
ing sequences of the CD40L cDNA were removed before
insertion into the expression cassette as these could play a
role in posttranscriptional regulation of the gene (19).
Founders were identified by PCR and Southern blot analy-
ses. To ascertain whether the transgene was being correctly
expressed, immunohistochemical analyses of cryostat sec-
tions of ears using an anti-CD40L antibody were per-
formed. A strong and uniform expression of CD40L by the
basal keratinocytes was detected in epidermis of CD40L Tg
mice (Fig. 1 B). No expression was detectable in the dermis
or epidermis of nonTg mice. Tg expression followed the
Figure 1. (A) K14/CD40L expression cassette used for the generation of the Tg mice. The construct contains the K14 promoter (arrow), the  -globin
intron (dotted box), the CD40L-cDNA (black box), and the K14 poly A  (hatched box). (B) Immunohistochemical staining of ear skin using an anti-
body directed against CD40L. Arrows point to the basal keratinocytes of the epidermis. Original magnification (left to right): 40 ; 200 ; 400 . 
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expected pattern in other tissues as has been described in
detail before (16) and, accordingly, was not found in other
organs such as liver, heart, intestine, kidney, brain, etc.
In comparison to their littermates, CD40L Tg mice ex-
hibited retarded growth, cachexia, and decreased survival
rates (Fig. 2, A and B). 
 
 
 
80% of the heterozygous off-
spring of CD40L Tg mice developed spontaneous derma-
titis at an average age of 47 d (Fig. 2 C). The onset of
dermatitis first became apparent by the reddening and
thickening of the ears followed by progressive inflamma-
tion usually encompassing the ears, snouts, and often the
upper thorax in the majority of the mice (Fig. 2, D and E).
Homozygous CD40L Tg mice were extremely frail and
developed additional massive skin alterations on tails,
neck, paws, and sometimes back (Fig. 2 F) which became
evident at 3–4 wk of age. These animals did not breed,
were particularly prone to cachexia, and died within 3–5
mo after birth.
 
Histologic Analyses of Skin.
 
Histopathological analysis of
H&E-stained sections of the ear or tail skin of CD40L Tg
mice revealed various abnormalities (Fig. 3, B and C). The
skin was characterized by a thickened acanthotic epidermis
and hyperkeratosis. Single necrotic keratinocytes were spo-
radically detectable within the basal cell layers. The dermal
connective tissue was fibrotic with increased numbers of fi-
broblasts. There was a massive mixed infiltrate of lympho-
histiocytic cells within the dermis although far fewer neu-
trophils than would be expected from a bacterial infection
were present. Focally, the number of hair follicles and seba-
ceous glands was reduced and some keratinous cysts were
present in association with a surrounding foreign body re-
action. Tissue from the paws was examined for possible in-
flammation of the joints. However, no signs of arthritis
were found (data not shown).
To further characterize the cells infiltrating the skin, im-
munohistochemical staining of cryostat sections of ears ex-
hibiting mild inflammation was performed. The dermis of
Tg mice contained large numbers of CD4
 
 
 
 and CD8
 
 
 
 T
cells (Fig. 3, E, F, H, and I) that were not detectable in the
skin of nonTg mice (Fig. 3, D and G). In addition, large
numbers of BM8
 
 
 
 cells were also present in the skin of Tg
mice, whereas only a few BM8
 
 
 
 cells were evident in the
dermis of nonTg mice (Fig. 3, J–L). This antibody reacts
with mature tissue macrophages as well as with LCs in the
skin. Interestingly, in comparison to the control mice,
there were increased numbers of large CD11c
 
 
 
 DCs in the
dermis of CD40L Tg mice but rarely in the epidermis (Fig.
3, N and O).
Figure 2. (A) Growth of male CD40L Tg mice and
their nonTg littermates, as assessed by their weight
gain. Tg mice are represented by squares and their lit-
termates by triangles. (B) Lifespan of CD40L Tg and
nonTg mice plotted using Kaplan and Meier curves.
Tg mice (n   30) are depicted by squares and their lit-
termates (n   10) by triangle. (C) Plot of the age (d) at
which skin lesions began to develop (n   38). The
mean age of 47 d is indicated by the horizontal line.
(D) Typical skin lesions of the ears and (E) snout of a
heterozygous CD40L Tg mouse. (F) Typical skin dis-
order of the tail of a homozygous mouse. 
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As CD40L is one of the most potent activators of DCs,
epidermal ear sheets of mice were stained for I-A to visu-
alize LCs in situ. Interestingly, in comparison to wild-type
mice which have a uniform network of LCs in the epider-
mis (Fig. 4 A), CD40L Tgs had a consistent reduction in
LCs of 
 
 
 
90% (Fig. 4 B, wild-type: 642 
 
  
 
125 LC/mm
 
2
 
;
CD40L Tg: 27 
 
  
 
22 LC/mm
 
2
 
). Furthermore, in large ar-
eas a “cobblestone” pattern of I-A-positive–activated ke-
ratinocytes was seen as has been described for other Tg
mice harboring immunomodulatory genes in the skin
(CD80, reference 14; CD54, reference 15; IFN-
 
 
 
, refer-
 
ence 9). The majority of visual fields was totally devoid of
LCs. In rare isolated areas, occasional very large I-A
 
 
 
 LCs
were observable (Fig. 4, C and D). Electron microscopic
analysis corroborated the results obtained by immunofluo-
rescence and immunohistochemical analyses of the epider-
mal sheets of the skin sections as the epidermis did not
contain any cells identifiable as LCs (data not shown).
Young CD40L Tg mice (day 18) also showed the same
marked reduction of epidermal LCs compared with age-
matched controls (18-d-old wild-type: 683
 
    
 
42 LC/
mm
 
2
 
; 18-d-old CD40L Tg mice: 23
 
    
 
9 LC/mm
 
2
 
).
Figure 3. H&E-stained paraffin-
embedded sections of (A) ears from
wild-type mice (original magnifica-
tion: 20 ) and (B and C) ears from
CD40L Tg mice. Original magnifi-
cation: 200 ; 400 . Immunohis-
tochemical staining of cryostat sec-
tions using antibodies directed against
(D–F) CD4, (G–I) CD8, (J–L) BM8,
and (M–O) CD11c. Original magni-
fication: 20 ; 200 ; 400 . 
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Again, the majority of visual fields were totally devoid of
LCs in day 18 Tg epidermis before onset of disease was
discernible (data not shown).
LCs are the major epidermal cell type that transports an-
tigen to the LNs and primes naive T cells. The absence of
DCs in the epidermis and the increase of activated DCs in
the dermis of Tg mice gave rise to the hypothesis that DC
turnover in the skin of CD40L Tg mice is enhanced. To
determine whether emigration of LCs from the skin of Tg
mice was increased, the hapten FITC was painted onto the
ears of 5–6-wk-old mice that had not yet fully developed
the skin lesions of the ears or their littermates and the LNs
were analyzed 18 h later. As shown in Fig. 5, flow cyto-
metric analyses of CD11c and FITC double-positive cells
revealed higher numbers of double-positive cells in the
LNs of Tg mice as compared with nonTg mice, suggesting
that more hapten-laden LCs had reached the LNs in the
CD40L Tg mice.
 
CD40L Tg Mice Develop LN Hyperplasia and Splenomeg-
aly.
 
CD40L Tg mice typically exhibited hyperplasia of the
regional LNs that drained inflamed areas. These invariably
included the cervical LNs. The sizes of other LNs were
comparable to those of wild-type mice. Furthermore, 58%
of the Tg mice exhibited splenomegaly.
The cellularity of the cervical LNs of CD40L Tgs was
greatly increased, and there was an overall increase in the
cell numbers within each individual leukocyte population
as examined by flow cytometry (Table I). Upon evaluation
of the relative percentages of the various leukocyte popula-
tions within the LNs, we found a decrease in the CD4
 
 
 
,
CD8
 
 
 
, and CD62L
 
 
 
 populations when comparing CD40L
Tg mice to wild-type animals. The relative percentages of
the expression of other cell surface markers were consis-
tently increased and particularly evident in the CD19
 
 
 
 (B
cell), CD11c
 
 
 
 (DC), and I-A
 
 
 
 populations.
To ascertain whether Tg expression had an effect on LN
architecture, paraffin sections were stained with H&E. In
addition, cryostat sections were stained for DCs (CD11c),
the B cells (CD19), and for T cells (CD4 and CD8). The
LNs of the CD40L Tg mice were very large and there
were many large germinal centers, consistent with the in-
crease in B cell numbers (Fig. 6 A; not all data shown).
Both the germinal centers of the spleen and the LNs were
characterized by follicular hyperplasia with increased man-
tle zone thickness. Some CD4
 
 
 
 T cells were not only dis-
persed throughout the T cell areas of the LNs but could
also be found within the B cell rich follicles of CD40L Tg
mice. In addition, large numbers of CD11c
 
 
 
 DCs were ev-
Figure 4. Fluorescence microscopy of I-A-positive cells in the earskin of nonTg (A and C; original magnification 100  and 400 , respectively), and
CD40L Tg mice (B and D; original magnification 100  and 400 , respectively). The yellow arrow points to LCs that are depicted at higher magnifica-
tion (400 ) in D. Note the “cobblestone” pattern of the I-A-positive keratinocytes. 
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ident (Fig. 6 A). As CD40L activates DCs, flow cytometric
analyses of the DC population revealed an increase in the
activation markers I-A, CD80, and CD86 (Fig. 6 B) as well
as strongly increased numbers of CD11c  /I-A , CD11c  /
CD80 , and CD11c /CD86  cells (Table II). Cervical LN
hyperplasia was also seen in young 18-d-old CD40L Tg
mice before the overt onset of disease with increased
CD19  (B cell), CD11c    (DCs), and I-A  populations
(data not shown).
Differences in the makeup of the spleen of Tg mice
compared with wild-type mice were not as pronounced,
except for the B cell population. In contrast to the LN,
there was a dramatic decrease in the relative percentages of
CD19  and I-A  cells in CD40L Tg mice when compared
with littermate control mice. On the other hand, the rela-
tive percentages of CD4  and CD8  T cells were similar
in both strains. Similar to the LN composition, there was
an increase in the relative percentages of CD11c  and
BM8  populations in the CD40L Tg mice. Analysis of
production of the cytokines TNF- , IL-4, IL-6, IL-12,
and IFN-  in LN, spleen, epidermis, and serum did not
reveal any significant differences between Tg and nonTg
mice (data not shown).
Although other LNs from the CD40L Tg mice, such as
the intraperitoneal LNs, were not enlarged, LN hyperplasia
could have been attributable to higher levels of soluble
CD40L in the serum of Tg mice. Therefore, Western blot
analysis of serum proteins was conducted. There were no
Table I. Weight, Cellularity, and Flow Cytometric Analyses of Cervical LNs and Spleensa
LN Spleen
Marker Wild-type CD40L Tg Wild-type CD40L Tg
Weight (mg) 9.4   1.0 76.3   8.2 107.6   8.3 238.1   40.5
Number of cells 3.0   106   0.9 43.8   106   8.7 79.3   106   11.6 307.1   106   53.6
BM8b 4.3   1.1 9.9   1.4 6.6   0.7 10.5   1.3
CD4 30.7   2.8 16.5   1.1 17.8   1.1 15.7   1.4
CD8 17.5   1.8 10.2   0.8 10.5   1.2 9.6   1.4
CD11c 3.8   0.4 8.5   1.3 8.9   0.8 11.9   0.9
CD19 29.9   4.6 41.8   2.6 57.9   2.3 37.2   3.6
CD40 24.3   3.4 40.3   2.4 63.9   1.9 51.4   3.7
CD62L 69.4   2.8 54.7   4.8 49.6   5.5 43.4   4.4
CD86 8.2   3.5 13.3   2.5 8.2   1.2 14.3   2.9
I-A 35.3   8.4 48.0   3.9 62.6   8.2 39.6   4.6
aData represent mean weights and cellularity of n   12 animals.
bSix mean percentages of positive cells   SEM of n   6 mice.
Figure 5. Flow cytometric analyses of
retroauricular LNs 18 h after FITC
treatment. FITC-treated LN cells from
CD40L Tg mice or their nonTg litter-
mates were stained for CD11c.622 Mice Expressing CD40L in the Skin Develop Inflammation and Autoimmunity
detectable differences in soluble CD40L levels between the
serum of Tg mice and the serum of control mice (data not
shown). Furthermore, the addition of 50  l of serum of a
CD40L Tg mouse with a strong phenotype to 3   106
bone marrow–derived DCs per 3 milliliter cultivated with
GM-CSF and IL-4 at day 6 did not generate any major dif-
ferences in the expression of the cell surface markers I-A,
CD86, CD40, ICAM-1, or CD11c in comparison to se-
rum from nonTg animals as determined by flow cytometric
analyses 2 d later (data not shown). These data suggest that
systemic concentrations of bioactive CD40L were below
the threshold required for in situ activation of DCs.
The increase in the B cell population warranted us to
look for changes in the serum Igs. Compared with nonTg
animals, the serum level of IgM was significantly decreased,
whereas the serum levels of IgG2a, IgG2b, IgE, and partic-
ularly IgG1 were significantly increased (Fig. 7). There was
no significant difference in the IgG3 and IgA serum levels
between the Tg and nonTg mice.
CD40L Tg Mice Develop Systemic Autoimmunity. To
determine whether the skin abnormalities of the CD40L
Tg mice could possibly be the result of an autoimmune re-
sponse, sera from wild-type and Tg mice were screened for
ANAs using HEp-2 cells. The sera from 13 of the 15
CD40L Tg mice tested scored positive and all controls
(n   5) scored negative. ANAs were detectable in Tg mice
as early as 5 wk of age. Although the patterns of ANA
staining of CD40L Tg mice were heterogeneous, CD40L
Tgs primarily exhibited antinucleolar staining with a pro-
nounced nuclear ring. Fig. 8 shows a typical negative (Fig.
Figure 6. (A) Immunohistochemical
staining of cryostat sections of cervical LNs
from a wild-type and a CD40L Tg mouse
(original magnification: 200 ) stained with
an antibody directed against CD11c.
Arrows point to B cell follicles; note the
differences in size. (B) Flow cytometric
analyses of CD11c  LN cells stained with
FITC-conjugated antibodies directed
against I-A, CD80, or CD86. DCs were en-
riched by gating according to forward and
side scatter characteristics.
Table II. Analysis of the DC Population of the LNs
Number of cells per LN
Wild-type CD40L Tg
CD11c /I-A   0.76   106a  7.7   106
CD11c /CD80   0.48   106  6.7   106
CD11c /CD86   0.49   106  7.9   106
Mean cellularity of CD11c /I-A , CD11c /CD80  , and CD11c /
CD86   cells in pooled cell suspensions of 18 wild-type (total cell number:
13.7   106) or 18 CD40L Tg (total cell number: 137.0   106) LNs.
aData represent mean cellularity of  18 pooled LNs.623 Mehling et al.
8 A) and positive (Fig. 8 B) staining of wild-type and
CD40L Tg mice, respectively.
The nuclear rim staining pattern was indicative of the
presence of anti-dsDNA antibodies. Serum samples were
therefore subjected to C. lucilidae assays. The kinetoplast of
this organism harbors large amounts of dsDNA only and
reactivity of autoantibodies can be used as a specific test for
the presence of anti-dsDNA autoantibodies. Of the 15 Tg
animals tested, 11 exhibited staining of the kinetoplast. All
control animals tested negative. Fig. 8, C and D show rep-
resentative negative and positive staining of the kinetoplast
resulting from indirect immunofluorescent staining of
nonTg or Tg serum Igs, respectively.
Autoimmune diseases are often associated with the in-
volvement of internal organs, in particular the kidneys and
sometimes the lungs, during disease progression (20).
Therefore, cryostat sections of kidneys were analyzed for
the presence of renal depositions of Igs and glomerulone-
phritis. Immunofluorescent staining of kidneys revealed
dense deposits of Igs within the mesangium of the glomer-
uli and within tubuli of CD40L Tg mice although only
mild infiltration by inflammatory cells was evident as as-
sessed by H&E staining. Of the 5 Tg mice tested, all exhib-
ited Ig deposits, whereas control mice showed no signifi-
cant deposits (Fig. 8, E and F). Clinically, these animals also
developed proteinuria indicating impairment of renal func-
tion. In addition, the lungs of some animals exhibited
pathological changes such as emphysema, fibrosis and, in-
terstitial inflammation (Fig. 8, G and H)
Autoreactive T Cells Initiate the Skin Manifestations in Tg
Mice. One of the hallmarks of autoimmunity is the pres-
ence of autoantibodies and/or autoreactive T cells that
elicit tissue damage. To ascertain whether autoantibodies
directed against skin components were present in the se-
rum of Tg mice indirect immunofluorescence staining was
performed. To this end, cryosections of ear or footpad skin
of nonTg mice were incubated with serum from Tg and
nonTg mice. Serum from Tg mice resulted in a distinct
intracellular staining of the basement membrane and basal
keratinocytes of the epidermis which was not observed
when serum from control mice was used (Fig. 8, I and J).
Thereupon, serum transfer was performed in order to de-
termine whether the autoantibodies themselves play a fun-
damental role in the initiation of the skin lesion develop-
ment. Neither serum from Tg nor serum from nonTg
mice elicited the development of skin disorders in nonTg
mice (data not shown).
These results pointed to a role of autoreactive T cells in
the generation of the CD40L Tg phenotype. To determine
whether this was indeed the case, T cells were prepared
from spleens as well as cervical and submandibular LNs of
Tg mice draining inflamed skin or control mice. From
these T cells CD4  or CD8  cells were purified as de-
scribed and injected into the tail vein of sex-matched recip-
ient mice. Other recipients received a mixture of both
CD4  and CD8  T cells. All recipient mice developed skin
lesions similar to those of CD40L Tg mice at an average of
18 plus or minus 4 d after injection of mixed CD4  and
CD8  T cells originating from the CD40L Tg mice (data
not shown). We next tested whether transferable pathology
is induced by highly purified CD4  or by CD8   T cells.
Interestingly, only recipients of CD8  T cells from Tgs
(Fig. 9, C and D), but not recipients of CD4  T cells from
Tgs (Fig. 9, A and B) developed skin lesions at an average
Figure 7. Ig levels in the se-
rum of Tg and nonTg mice.
Scatter diagrams and mean val-
ues     SEM of the serum Igs
tested (n   10 mice are shown).
P values are indicated. *Depicts
Student’s t test values, P   0.05. 624 Mice Expressing CD40L in the Skin Develop Inflammation and Autoimmunity
of 7 plus or minus 2 d, suggesting that upon transfer, the
CD8  T cells are primarily able to induce autoimmune skin
inflammation. The recipient mice did not develop skin dis-
orders when the T cells isolated from nonTg mice were
used for injection. These data indicate that among the
CD8  T cells, autoreactive T cells are indeed present,
which are directed against components of the skin and that
this specific autoreactivity is transferable.
To elucidate the role of the B cells in the elicitation of
the autoimmune response, CD40L Tg mice were back-
crossed into the B cell–deficient mouse strain JHT (21). B
cell–deficient CD40L Tg mice exhibited a similar inflam-
Figure 8. (A) Typical nega-
tive indirect fluorescent staining
of HEp2 cells incubated with
serum from control mice. (B)
Typical positive staining of
HEp2 cells incubated with se-
rum from a CD40L Tg mouse.
Original magnification 400 ;
serum dilution 1:80. (C) Typical
negative indirect fluorescent
staining of C. lucilidae cells incu-
bated with serum from control
mice. (D) Typical positive stain-
ing of the kinetoplast (arrow) of
C. lucilidae cells incubated with
serum from a CD40L Tg mouse.
Original magnification: 1,000 ;
serum dilution 1:40. (E and F)
Immunofluorescence staining of
renal deposits of Igs. (G and H)
H&E staining of lung tissue. (I
and J) Indirect immunofluores-
cent staining of immune deposits
in nonTg mouse footpad skin
after incubation with serum
from a nonTg mouse (I) or a
CD40L Tg mouse (J).625 Mehling et al.
matory phenotype with the typical involvement of the ears,
snouts, paws, and tail (Fig. 9 E).
Discussion
The current study was initiated to investigate the effects
of continuous activation of tissue resident DCs. Thus, Tg
mice were generated that overexpress CD40L in the basal
keratinocytes of the epidermis. These mice acquired a
striking phenotype with severe spontaneous inflammatory
skin lesions, a 90% reduction in LC numbers in the ear-
skin, hyperplasia of the lymph nodes draining from in-
flamed areas, and a high mortality rate. Surprisingly, these
animals also developed systemic autoimmunity as made
evident by the presence of autoantibodies and autoreactive
T cells.
Figure 9. (A and B) Ear of a nonTg mouse 4 wk after transfer of CD4  T cells from CD40L Tg mice. H&E-stained histology section. Original mag-
nification 200 . (C and D) Typical skin pathology of a nonTg mouse 4 wk after transfer of CD8  T cells from CD40L Tg mice. H&E-stained histology
section. Original magnification: 40 . (E) Ear of a B cell–deficient (JHT) CD40L Tg mouse.626 Mice Expressing CD40L in the Skin Develop Inflammation and Autoimmunity
The degree of the reduction in LC numbers within the
skin was surprising. This might be due to impaired immi-
gration of LCs into the epidermis, enhanced activation-
induced apoptosis of LCs in situ, or increased migration of
CD40L-activated LCs from the skin to the LN. To this
end, McLellan et al. recently reported that mature DCs are
induced to undergo apoptosis after cross-linking by MHC
class II (22). Although keratinocytes of CD40L Tg mice
expressed MHC class II, the same group demonstrated that
pretreatment of DCs with an agonistic anti-CD40 antibody
rendered DCs completely resistant to MHC class II–
induced apoptosis. This data argues against enhanced apop-
tosis of the LCs in the skin. A role in the migration of LCs
to the LNs has recently been ascribed to CD40L (23). LCs
of CD40L /  mice failed to migrate out of the skin after
contact sensitization and this defect was correctable by in-
jection of an agonistic anti-CD40L antibody. In agreement
with this, the converse effect was evident in our CD40L
Tg mice, which further substantiates the role of CD40L in
the migration of DCs. Moreover, the increase in the
CD11c  population within the dermis, the increased num-
bers of CD11c  cells within the LN, the increased numbers
of FITC-positive DCs in the LNs after FITC sensitization
as well as increased migratory capacities of CD40L-treated
DCs (24) all might suggest that LC migration is enhanced
in the CD40L Tg mice.
The predominant proportion of CD40L Tg mice devel-
oped spontaneous dermatitis between 4-6 wk after birth.
The skin was characterized by hyperkeratosis, sporadic sin-
gle cell necrosis of keratinocytes, a dense dermal infiltrate
of lymphohistiocytic cells, and dermal fibrosis. Dermatitis
occurred although the animals were housed under specific
pathogen free–conditions excluding the involvement of
exogenous pathogens in the onset of disease. These histo-
logical features are congruent with a local autoimmune re-
sponse against the skin and can be also be found in human
autoimmune skin disorders such as cutaneous lupus erythe-
matosus (25, 26).
Autoimmune disorders are characterized by the failure of
the immune system to discriminate between self-determi-
nants and foreign antigens. According to Drexhage et al.,
two major criteria define autoimmune disease. (i) IgG au-
toantibodies and/or autoreactive T cells specific for anti-
gens of the particular organ or organ system must be
present, which in turn trigger the development of morpho-
logical lesions. (ii) A similar manifestation of disease can be
induced by the transfer of autoantibodies or the autoreac-
tive T cells (27). Our findings indicate that T cells are the
primary effector cells involved in the development of local
autoimmunity in our model system as only the transfer of T
cells from CD40L Tg mice and not the transient presence
of transferred autoantibodies resulted in the development
of local autoimmune dermatitis in the recipient mice. In
other models of autoimmunity, tissue damage only oc-
curred when some sort of local inflammatory stimulus was
present (28). Not even IFN- –overexpressing mice, which
develop flaky skin lesions, hypopigmented hair, ANAs, and
nephritis were reported to have autoreactive T cells (10). In
the skin, weak stimuli such as low-dose UV-irradiation,
scratching, and even stretching of the skin has been re-
ported to induce the release of proinflammatory cytokines,
which might explain why adoptive transfer of autoreactive
T cells from Tg mice causes spontaneous pathology in
wild-type recipients (29). Importantly, B cells did not seem
to be involved in this process as B cell–deficient/CD40L
Tg mice also develop chronic dermatitis.
Surprisingly, overexpression of CD40L in the epidermis
not only led to the local autoimmune skin inflammation,
but also to the development of a systemic autoimmune dis-
ease as evidenced by the presence of ANAs, anti-dsDNA
antibodies, and the typical involvement of internal organs.
Whether autoreactive T cells upon transfer into recipient
mice on their own are capable of inducing systemic au-
toimmunity will be interesting to see and investigations are
currently being performed to address this aspect. To this
end, long-term observation periods of recipients of CD40L
Tg T cells are being performed to see whether systemic au-
toimmunity will develop. It was proposed that the activa-
tion status of APCs is a cardinal factor defining the out-
come of immunity versus autoimmunity (30). In particular
in a recent report, stimulation of APCs via ligation of
CD40 plays a role in “breaking” tolerance (31). Our study
strongly supports this concept. We speculate that CD40L-
stimulated LCs possibly internalize autoantigens, present
them to T cells, and thus may initiate autoantigen-induced
T cell proliferation which in turn could lead to the autore-
active skin inflammation. Whether the LCs activated in the
skin by the Tg expression of CD40L were able to directly
induce CTL activity against self-antigens thereby eliciting
the autoimmune manifestations remains to be seen. No de-
tectable production of inflammatory cytokines was found
by keratinocytes from CD40L Tg mice, probably because
in contrast to human keratinocytes, which constitutively
express CD40, murine keratinocytes do not (32).
A number of pathological immune disorders are associ-
ated with aberrant CD40–CD40L signaling and document
the key role of this receptor–ligand pair in immune re-
sponses. The human hyper IgM syndrome, an X-linked
immunodeficiency, in which a genetic alteration has ren-
dered the CD40L molecule nonfunctional, is characterized
by deficiencies in the induction of somatic mutations re-
sulting in high serum levels of IgM and little or no IgG,
IgA, or IgE antibodies (33). The opposite effect was seen in
the CD40L Tg mice. These mice had a significant reduc-
tion in their IgM serum levels and significantly increased
levels of IgG1, IgG2a, IgG2b, and IgE. Moreover, these
mice had a considerable increase in B cells numbers and
hyperplasia of the LNs draining from affected skin. These
effects did not result from detectable increased serum levels
of sCD40L in the serum Tg mice. Furthermore, LN hyper-
plasia was limited to LNs draining inflamed areas substanti-
ating the evidence that no considerably increased amounts
of sCD40L were in the serum. This suggests that other fac-
tors resulting from CD40L overexpression in the skin
could be responsible for the isotype switching and the B
cell proliferation. DCs themselves can directly enhance B627 Mehling et al.
cell proliferation since human DCs were shown to enhance
proliferation of activated B cells by a three to sixfold in
vitro (34). Furthermore, studies with CD40 knockout mice
revealed that DCs can also prolong B cell survival as well as
enhance their proliferation (35). In a recent study, DCs ge-
netically modified to produce CD40L were able to induce
B cell–dependent humoral immunity in CD4 T cell–defi-
cient mice (36). Hence, the increase in the B cell popula-
tion of the Tg mice is also indicative of a direct influence of
the increased numbers of DCs within the LN.
In this study, several lines of evidence suggest that the
continuous activation of epidermal LCs by CD40L may
lead to the development of chronic skin inflammation and
the subsequent development of systemic autoimmunity.
The data furthermore indicate a possible role for tissue-res-
ident DCs in the induction of autoimmunity. CD40L Tg
mice exhibit aspects of mixed connective tissue disease.
This disease is an overlap syndrome that includes aspects of
lupus erythematosus, scleroderma, and/or dermatomyositis
(20, 24, 37). Analogously, CD40L Tg mice exhibit the
speckled type pattern of antinuclear antibodies, anti-dsDNA
antibodies, visible linear depositions at the dermoepidermal
junction after indirect immunofluorescent staining, in addi-
tion to renal, lung, and skin manifestations that are also
found in mixed connective tissue disease. In this context, it
is important to mention that CD40–CD40L signaling has
also been implicated in several human autoimmune disor-
ders (3, 38). Studies have revealed that activated T cells
from patients with systemic lupus erythematosus or sclero-
derma have a prolonged expression of CD40L when com-
pared with healthy control groups (39, 40). Furthermore,
in systemic lupus erythematosus patients disease activity is
directly associated with elevated plasma levels of CD40L
(41). Mori et al. also reported the findings that in the le-
sional epidermis, the expression of HLA-DR antigens by
epidermal DCs was reduced and fewer CD1a  DCs (LCs)
were present in comparison to normal skin (42), which is
consistent with the extremely reduced numbers of LCs in
the epidermis of CD40L Tg mice. The pathological find-
ings in CD40L Tg mice therefore suggest that these Tgs
represent a potentially interesting animal model for study-
ing mixed connective tissue disease. Moreover, they have
the potential of being an excellent model for dissecting the
T cell and Ig/B cell–dependent pathways leading to au-
toimmune disease development.
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